The link between IL-1 activity and HF is supported by elevated circulating levels of IL-1β as well as surrogate biomarkers such as IL-6 or CRP, each of which correlates with worsening HF symptoms and outcomes [23,24,25,26,27,45]. This evidence concerns the gene IL6 and hydrops fetalis.